ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 193031 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
+1.8%
Revenue CAGR (3yr)
13.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $14M | $14M | $15M | +6.1% | +1.8% |
| Operating Expenses | $13M | $12M | $13M | +5.2% | -0.7% |
| Operating Margin | 8.7% | 12.3% | 13.1% | +5.9% | +22.2% |
| Net Income | $1M | $2M | $2M | +12.4% | +24.4% |
| Licensed Beds | 47 | 47 | 47 | +0.0% | +0.0% |
| Total Patient Days | 10,624 | 10,084 | 10,053 | -0.3% | -2.7% |
| Medicare Day % | 58% | 47% | 53% | +12.6% | -3.9% |
| Medicaid Day % | 2% | nan% | 0% | +nan% | -79.0% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +3.6% ($14M → $15M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.8%
This Hospital
+7.6%
State Avg
Latest Margin
13.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | 15.2% |
| FY2024 (proj) | $15M | 17.4% |
| FY2025 (proj) | $16M | 19.6% |